L‐Proline Derived Thioamide Small Organic Molecule for the α‐Stereoselective Synthesis of 2‐Deoxyglycosides
Advanced Synthesis & Catalysis · 05.09.2023 · 365 (17) · 2949-2958
DOI: 10.1002/adsc.202300455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 04.08.2023. Verfasst von Ashwani Tiwari und 4 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 142 Literaturangaben.
Abstract (Originalsprache)
L‐Prolinethioamide catalyzes direct stereoselective glycosylation of glycal donors to access 2‐deoxyglycosides under moderate reaction conditions. This proposed glycosylation protocol produced the desired products in up to 88% yield and shows greater tolerance of glycosyl acceptors and a broad substrate scope with better stereoselectivity. This method is also applicable for less nucleophilic acceptors such as phenol. In addition, 1,1′‐linked trehalose‐type analogues can also be accessed through this methodology. Further, mechanistic studies suggest that, in this glycosylation, L‐prolinethioamide operates via Brønsted acid/base catalysis.
Zitieren
APA
Tiwari, A., Khanam, A., Kumar, A., Lal, M., & Mandal, P. K. (2023). L‐Proline Derived Thioamide Small Organic Molecule for the α‐Stereoselective Synthesis of 2‐Deoxyglycosides. Advanced Synthesis & Catalysis, 365(17), 2949-2958. https://doi.org/10.1002/adsc.202300455
Vancouver
Tiwari A, Khanam A, Kumar A, Lal M, Mandal PK. L‐Proline Derived Thioamide Small Organic Molecule for the α‐Stereoselective Synthesis of 2‐Deoxyglycosides. Advanced Synthesis & Catalysis. 2023;365(17):2949-2958. doi:10.1002/adsc.202300455
BibTeX
@article{Tiwari2023,
author = {Tiwari, Ashwani and Khanam, Ariza and Kumar, Ashwani and Lal, Mohan and Mandal, Pintu Kumar},
title = {L‐Proline Derived Thioamide Small Organic Molecule for the α‐Stereoselective Synthesis of 2‐Deoxyglycosides},
journal = {Advanced Synthesis & Catalysis},
year = {2023},
volume = {365},
number = {17},
pages = {2949--2958},
doi = {10.1002/adsc.202300455}
}
EUVIMED